<DOC>
	<DOCNO>NCT02552459</DOCNO>
	<brief_summary>The purpose study determine effect combine medication sufentanil dexmedetomidine patient control analgesia neurosurgery .</brief_summary>
	<brief_title>Effect Dexmedetomidine Combined With Sufentanil Postoperative Intravenous Analgesia Neurosurgery</brief_title>
	<detailed_description>Sufentanil classical drug postoperative analgesia . Dexmedetomidine commonly use Î±2-adrenergic receptor , help provide sedation , analgesia inhibition sympathetic activation . The investigator propose recruit 120 patient undergo arteriovenous malformation embolism operation department Neurosurgery . Patients randomly divide 4 group ( control group , sufentanil low dexmedetomidine dose group , sufentanil middle dexmedetomidine dose group , sufentanil high dexmedetomidine dose group ) , investigator select post-operative record determine whether dexmedetomidine take positive role neurosurgical analgesia .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>1. patient undergo venous malformation embolization operation general anesthesia . 2. aged 1865 year old . 3. operating time vary 14h , extubation operation . 1. longterm use analgesic , sedative non steroidal antiinflammatory drug history . 2. known dexmedetomidine drug allergy study . 3. communicate . 4. preoperative systolic blood pressure &lt; 90 mmHg , heart rate &lt; 50/min .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dexmedetomidine</keyword>
	<keyword>patient control analgesia</keyword>
</DOC>